“共富区”建设背景下普惠式健康险发展路径研究——以天一甬宁保为例

赵静

中国医疗保险 ›› 2025, Vol. 0 ›› Issue (4) : 113-119.

中国医疗保险 ›› 2025, Vol. 0 ›› Issue (4) : 113-119. DOI: 10.19546/j.issn.1674-3830.2025.4.015
商保天地

“共富区”建设背景下普惠式健康险发展路径研究——以天一甬宁保为例

  • 赵静
作者信息 +

Research on the Development Path of Inclusive Health Insurance Under the Background of "Demonstration Zone for Common Prosperity" Construction——Taking Tianyi Yongning Insurance as an Example

Author information +
文章历史 +

摘要

目的: 研究普惠式健康险实现可持续发展的困难与对策。方法: 在“共富区”建设背景下,以宁波市为例,深入分析天一甬宁保的产品特点、面临挑战与存在问题,提出未来发展的建议。结果: 及结论:当前,天一甬宁保面临的主要挑战是“逆向选择”风险大、产品吸引力不足。具体问题包括赔付规则复杂、产品定位不明、激励机制缺失、支付效率不高以及政企责任不清。建议: 天一甬宁保应在发挥普惠功能的同时,回归一定的市场属性,通过实施产品责任分级、优化赔付规则、健全激励措施、创新支付方式、合理划分政企责任、优化风险管控机制等措施,有效提升产品吸引力。

Abstract

Objective: The paper studies the countermeasures for the sustainable development of inclusive health insurance. Methods: Under the Backgroundof “Demonstration Zone for Common Prosperity” Construction, this paper deeply analyzes the product characteristics, challenges, and problems of Tianyi Yongning Bao taking Ningbo City as an example, and puts forward suggestions for future development. Resultsand Conclusion: Currently, Tianyi Yongning Insurance is facing challenges mainly due to the high risk of "adverse selection" and the insufficient attractiveness of the product. Specific issues are complex compensation rules, unclear product positioning, lack of incentive mechanisms, low payment efficiency, and unclear responsibilities of government and enterprises. Suggestions: Tianyi Yongning Insurance should return to a certain market attribute while leveraging its inclusive function, which can be achieved through implementing product liability grading, perfecting compensation rules, improving incentive measures, innovating payment methods, reasonably allocating responsibilities between government and enterprises, optimizing product risk control mechanisms, to effectively improve attractiveness of the product.

关键词

普惠式健康险 / 惠民保 / 天一甬宁保 / 共富区

Key words

inclusive health insurance / city-customized commercial health insurance / Tianyi Yongning Insurance / demonstration zone for common prosperity

引用本文

导出引用
赵静. “共富区”建设背景下普惠式健康险发展路径研究——以天一甬宁保为例[J]. 中国医疗保险. 2025, 0(4): 113-119 https://doi.org/10.19546/j.issn.1674-3830.2025.4.015
Research on the Development Path of Inclusive Health Insurance Under the Background of "Demonstration Zone for Common Prosperity" Construction——Taking Tianyi Yongning Insurance as an Example[J]. China Health Insurance. 2025, 0(4): 113-119 https://doi.org/10.19546/j.issn.1674-3830.2025.4.015
中图分类号: F840.684    C913.7   

参考文献

[1] 李玉华.普惠性商业医疗保险的实践及路径优化研究[J].卫生经济研究,2024,41(10):20-23.
[2] 浙江省医疗保障局.关于深化浙江省惠民型商业补充医疗保险改革的指导意见[EB/OL].(2022-11-22)[2025-02-10].http://ybj.zj.gov.cn/art/2022/11/22/art_1229113757_2447998.html.
[3] 浙江省医疗保障局.关于省十四届人大一次会议第47号建议的答复[EB/OL].(2023-07-03)[2025-02-10].http://ybj.zj.gov.cn/art/2023/7/3/art_1229226152_5135972.html.
[4] 宁波市地方金融监管局.衔接基本医保,保障全面升级,2023年度“天一甬宁保”正式发布[EB/OL].(2022-09-20)[2025-02-10].http://jrb.ningbo.gov.cn/art/2022/9/20/art_1229024326_58897178.html.
[5] 宁波市发改委.2024年度“天一甬宁保”亮相[EB/OL].(2023-10-11)[2025-02-10].https://fgw.ningbo.gov.cn/art/2023/10/11/art_1229020604_58964589.html.
[6] 毕马威中国(KPMGChina).最新数据洞察:2024年惠民保发展如何?[EB/OL].(2024-04-03)[2025-02-10].https://www.sohu.com/a/768893517_120070887.
[7] 宁波市医保局.宁波市医保相关数据(2023年)[EB/OL].(2024-03-22)[2025-02-10].http://ybj.ningbo.gov.cn/art/2024/3/22/art_1229143745_4372263.html.
[8] 余姚发布.10个月赔付5000多万元!我市超1.5万人受益于“天一甬宁保”[EB/OL].(2024-11-28)[2025-02-10].https://mp.weixin.qq.com/s?__biz=MzA3MTI2MTAzMA==&mid=2651395388&idx=1&sn=c85fe6712f20df2aca28eaa02a76b03d&chksm=85ac2a9947dd13b53ffdf112cd04f07b5093408a4713f377123021059048f0c5b9c2c1b7fa98&scene=27.
[9] 宁波市医疗保障局.关于印发《宁波市促进商业补充医疗保险发展进一步完善多层次医疗保障体系实施方案》的通知[EB/OL].(2021-10-09)[2025-02-10].http://ybj.ningbo.gov.cn/art/2021/10/9/art_1229143683_58724675.html.
[10] 国家医疗保障局.2023年全国医疗保障事业发展统计公报[EB/OL].(2024-07-25)[2025-02-10].https://www.nhsa.gov.cn/art/2024/7/25/art_7_13340.html.
[11] 于保荣.中国社会医疗保险制度未来发展的挑战与创新建议[J].卫生经济研究,2024,41(1):20-28.
[12] 国务院办公厅.关于健全基本医疗保险参保长效机制的指导意见[EB/OL].(2024-08-01)[2025-02-10].https://www.gov.cn/zhengce/zhengceku/202408/content_6965742.htm.
[13] 陈晶.医药消费者行为学[M].北京:清华大学出版社,2010:174-176.
[14] 21世纪经济报道.2024国谈初审名单出炉:440个药品通过,创新药或成最大赢家[EB/OL].(2024-08-09)[2025-02-10].https://www.163.com/dy/article/J93FBCGN05199NPP.html.
[15] 王宇佳.我国普惠健康险发展研究——以惠民保为例[D].石家庄:河北经贸大学,2022.
[16] 蔺淼,丁锦希.惠民保城市定制型商业医疗保险的制度创新与优化设计[J].价格理论与实践,2023(04):148-152+210.

Accesses

Citation

Detail

段落导航
相关文章

/